MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

Mostrar otras versiones (1)

BACKGROUND: Neuroblastoma remains a major cause of cancer-linked mortality in children. miR-204 has been used in microRNA expression signatures predictive of neuroblastoma patient survival. The aim of this study was to explore the independent association of miR-204 with survival in a neuroblastoma c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, J, Tivnan, A, Fay, J, Bryan, K, Meehan, M, Creevey, L, Lynch, J, Bray, I M, O'Meara, A, Davidoff, A M, Stallings, R L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464768/
https://www.ncbi.nlm.nih.gov/pubmed/22892391
http://dx.doi.org/10.1038/bjc.2012.356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464768/
https://www.ncbi.nlm.nih.gov/pubmed/22892391
http://dx.doi.org/10.1038/bjc.2012.356

Ejemplares similares